| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 5e-05 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |